Agile Therapeutics Inc Book/Share
What is the Book/Share of Agile Therapeutics Inc?
The Book/Share of Agile Therapeutics Inc is -1.04
What is the definition of Book/Share?
Book value per share is a company’s assets minus liabilities divided by the number of shares outstanding.
mrq (most recent quarter)
The book value of a company is the value of its assets according to its balance sheet account balance. For assets, the value is based on the original cost of the asset less any depreciation, amortization or impairment costs made against the asset. Traditionally, a company's book value is its total assets minus intangible assets and liabilities. However, in practice, depending on the source of the calculation, book value may variably include goodwill, intangible assets, or both. The value inherent in its workforce, part of the intellectual capital of a company, is always ignored. The book value of a company may be also referred as with the term net asset value.
The book value per share is the the balance sheet equity value divided by the number of shares outstanding at the date of the balance sheet. Book value per share can be used to generate a measure of comprehensive earnings, when the opening and closing values are reconciled. The sale of shares/units by a business increases the total book value. Book value per share will increase if the additional shares are issued at a price higher than the pre-existing book value per share. The purchase of its own shares by a business will decrease total book value. Book value per share will decrease if more is paid for them than was received when originally issued. Dividends paid out will decrease book value per share value.
Book/Share of companies in the Health Care sector on NASDAQ compared to Agile Therapeutics Inc
What does Agile Therapeutics Inc do?
agile therapeutics is a forward-thinking women's healthcare company dedicated to fulfilling the unmet health needs of today's women. our product candidates are designed to provide women with contraceptive options that offer freedom from taking a daily pill, without committing to a longer-acting method. our lead product candidate, twirla®, (ethinyl estradiol and levonorgestrel transdermal system), also known as ag200-15, is a once-weekly prescription contraceptive patch that recently completed phase 3 trials. twirla is based on our proprietary transdermal patch technology, called skinfusion®, which is designed to provide advantages over currently available patches and is intended to optimize patch adhesion and patient wearability. for more information, please visit the company website at www.agiletherapeutics.com. connect with us on twitter at @agilether.
Companies with book/share similar to Agile Therapeutics Inc
- Akerna Corp has Book/Share of -1.07
- Predilife S.A has Book/Share of -1.07
- Armata Pharmaceuticals Inc has Book/Share of -1.06
- C & C Constructions has Book/Share of -1.06
- C & C Constructions has Book/Share of -1.06
- Xiana Mining has Book/Share of -1.05
- Agile Therapeutics Inc has Book/Share of -1.04
- Global Wellness Strategies has Book/Share of -1.04
- Rochester Resources has Book/Share of -1.03
- Les Hotels de Paris SA has Book/Share of -1.03
- Uxin Ltd has Book/Share of -1.03
- Opthea Ltd has Book/Share of -1.02
- Trinseo PLC has Book/Share of -1.02